Retatrutide 5mg 10mg kumu kūʻai maʻalahi
inoa huahana: Retatrutide
Hōʻike: 5mg * 10vial / pahu 10mg * 10vials / kit
MOQ:1kit
Kumukuai: 5mg USD320/kit 10mg USD600/kit
Kahi i kumu: Kina
Retatrutide
Ke hoʻomohala ʻia nei ka Retatrutide (LY-3437943) no ka mālama ʻana i ka maʻi diabetes mellitus type 2, obstructive sleep apnea, osteoarthritis, obesity a me ka maʻi ʻaʻai momona ʻole.Hāʻawi ʻia ka moho lāʻau ma ke ala subcutaneous a intravenous.Hana ka moho lāʻau lapaʻau ma ka huli ʻana i ka glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), a me nā mea hoʻokipa glucagon.He mea molekala hou.
Hana ʻo Retatrutide i ka mālama ʻana i ka momona ma ka huli ʻana i ʻekolu mau hormone hoʻoponopono pōloli: – GIP (gastric inhibitory peptide or glucose-dependent insulinotropic polypeptide) he hormone incretin i hoʻokuʻu ʻia mai ka ʻōpū ma hope o ka ʻai ʻana.Hoʻoulu ka Retatrutide i nā beta-cell i loko o ka pancreas e huna i ka insulin. ʻO ka lāʻau lapaʻau he peptide me ke kaʻina amino acid.He triple hormone receptor agonist o GLP-1, GIP, a me GCGR receptors.Ua hōʻike ʻia i ka loaʻa ʻana o kahi ʻoi aku ma mua o 24% mean ka hoʻemi kaumaha i nā pākeke ʻaʻole maʻi maʻi a i ʻole ke kaumaha.
Ua like ka Retatrutide me Ozempic, Wegovy, a me Mounjaro no ka mea, he hoʻokahi pule i kēlā me kēia pule o nā hormones e hoʻololi i ke ʻano o kā mākou ʻai, e alakaʻi ana i nā manaʻo mua o ka piha a me ka emi ʻana o ka makemake.
Akā ʻaʻole like me Ozempic a me Wegovy, e hoʻohālike ana i hoʻokahi hormone hoʻoponopono pōloli (GLP-1), a i ʻole Mounjaro, e hoʻohālike ana i ʻelua mau hormones (GLP-1 a me GIP),retatrutidehe mole hoʻokahi e hoʻohālike ana i ʻekolu mau hormones hoʻoponopono pōloli: GLP-1, GIP, a me glucagon.ʻO kēlā hana "triple G", e like me kā kekahi poʻe ʻepekema i kapa ai ma ka hālāwai, ʻoi aku ka ikaika o ka hopena i ka makemake a me ka māʻona o ke kanaka i ka meaʻai.
I ka ho'āʻo i paʻi ʻia ma ka NEJM, nā maʻi me ka momona i hāʻawi ʻia i ka nui o ka pule hebedomaretatrutide(12 mg) lilo i ka awelika o 58 paona i loko o 11 mahina.Ke emi mau nei ko lākou kaumaha ʻoiai i ka pau ʻana o ka hoʻāʻo ʻana, e manaʻo ana he lōʻihi, ʻoi aku ka nui o nā hoʻāʻo e hoʻopau ʻia e hiki ke hāʻawi i nā hopena pohō kaumaha.ʻO kēlā me kēia mea maʻi ma ke ʻano kiʻekiʻe loa o ka retatrutide ua nalowale ma ka liʻiliʻi he 5% o ko lākou kaumaha kino, a ʻo ka hapaha o kēlā poʻe i komo i nalowale he 30% a ʻoi aku paha o ko lākou kaumaha.
Ma kahi noiʻi like ʻana o ka retatrutide no nā poʻe maʻi me ka maʻi maʻi type 2 i paʻi ʻia ma The Lancet, ua nalowale nā mea maʻi ma kahi o 17% o ko lākou kino i loko o ʻeiwa mau mahina, he hana kupaianaha ia, no ka mea, ʻoi aku ka paʻakikī o ka poʻe maʻi me T2D e nalowale ka nui o ke kaumaha. e like me nā poʻe ʻē aʻe me ke kaumaha a me ka momona.
HOOLAHA
Hoʻouna mākou ma ka honua holoʻokoʻa.
Pono ʻoe e nīnau i kāu mau kūkākūkā olakino ma mua o ka hoʻohana ʻana i ka huahana.